Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress

被引:172
作者
Hayakawa, J
Mittal, S
Wang, Y
Korkmaz, KS
Adamson, E
English, C
Omichi, M
McClelland, M
Mercola, D
机构
[1] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
[2] Burnham Inst, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Rebecca & John Moores Canc Ctr, La Jolla, CA 92093 USA
[4] Osaka Univ, Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/j.molcel.2004.10.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NH2-terminal Jun kinases (JNKs) function in diverse roles through phosphorylation and activation of AP-1 components including ATF2 and c-Jun. However, the genes that mediate these processes are poorly understood. A model phenotype characterized by rapid activation of Jun kinase and enhanced DNA repair following cisplatin treatment was examined using chromatin immunoprecipitation with antibodies against ATF2 and c-Jun or their phosphorylated forms and hybridization to promoter arrays. Following genotoxic stress, we identified 269 genes whose promoters are bound upon phosphorylation of ATF2 and c-Jun. Binding did not occur following treatment with transplatin or the JNK inhibitor SP600125 or JNK-specific siRNA. Of 89 known DNA repair genes represented on the array, 23 are specifically activated by cisplatin treatment within 3-6 hr. Thus, the genotoxic stress response occurs at least partly via activation of ATF2 and c-Jun, leading to large-scale coordinate gene expression dominated by genes of DNA repair.
引用
收藏
页码:521 / 535
页数:15
相关论文
共 75 条
[1]   COMPLEXES OF P21(RAS) WITH JUN N-TERMINAL KINASE AND JUN PROTEINS [J].
ADLER, V ;
PINCUS, MR ;
BRANDTRAUF, PW ;
RONAI, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10585-10589
[2]   ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1 [J].
ANGEL, P ;
ALLEGRETTO, EA ;
OKINO, ST ;
HATTORI, K ;
BOYLE, WJ ;
HUNTER, T ;
KARIN, M .
NATURE, 1988, 332 (6160) :166-171
[3]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[4]   Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential [J].
Bogoyevitch, MA ;
Boehm, I ;
Oakley, A ;
Ketteman, AJ ;
Barr, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :89-101
[5]   Transcription - Signal transduction and the control of gene expression [J].
Brivanlou, AH ;
Darnell, JE .
SCIENCE, 2002, 295 (5556) :813-818
[6]   INDUCTION OF C-FOS EXPRESSION THROUGH JNK-MEDIATED TCF/ELK-1 PHOSPHORYLATION [J].
CAVIGELLI, M ;
DOLFI, F ;
CLARET, FX ;
KARIN, M .
EMBO JOURNAL, 1995, 14 (23) :5957-5964
[7]  
Chen NY, 2002, CANCER RES, V62, P1300
[8]   MESSENGER-RNA LEVELS OF XPAC AND ERCC1 IN OVARIAN-CANCER TISSUE CORRELATE WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY [J].
DABHOLKAR, M ;
VIONNET, J ;
BOSTICKBRUTON, F ;
YU, JJ ;
REED, E .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :703-708
[9]  
Dalgaard P, 2002, STAT COMPUTING INTRO
[10]  
Davis PL, 1998, ANTICANCER RES, V18, P2919